Viridian Therapeutics, Inc. (VRDN) Misses Q4 EPS by 37c

Viridian Therapeutics, Inc. (NASDAQ: VRDN) reported Q4 EPS of ($1.35), $0.37 worse than the analyst estimate of ($0.98).

For earnings history and earnings-related data on Viridian Therapeutics, Inc. (VRDN) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• 51Talk Online Education Group (COE) Reports Q1 EPS of $0.00
• The Lovesac Company (LOVE) Tops Q1 EPS by 29c